5'-(N-环丙基)甲酰胺腺苷，CAS 登记号 50908-62-8，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 5'-(N-环丙基)甲酰胺腺苷 的 CAS 号：50908-62-8，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
5'-(N-cyclopropyl)carboxamidoadenosine · CAS 50908-62-8 · C13H16N6O4. UNII HMS2235M15.
| CAS Registry Number | 50908-62-8 |
|---|---|
| PubChem CID | 1761 |
| Molecular formula | C13H16N6O4 |
| IUPAC name | 5-(6-aminopurin-9-yl)-N-cyclopropyl-3,4-dihydroxyoxolane-2-carboxamide |
| UNII (FDA) | HMS2235M15 |
| Molecular Weight | 320.30 |
|---|---|
| XLogP3 | -0.5 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 3 |
| Exact Mass | 320.12330301 |
| Monoisotopic Mass | 320.12330301 |
| Topological Polar Surface Area | 148 |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Reported hazard statements | H300 (100%), H310 (100%), H330 (100%) |
|---|
H300 (100%): Fatal if swallowed [Danger Acute toxicity, oral]
H310 (100%): Fatal in contact with skin [Danger Acute toxicity, dermal]
5'-(N-Cyclopropyl)carboxamidoadenosine; 5'-(N-CYCLOPROPYL)-CARBOXAMIDOADENOSINE; REGID_for_CID_1761; MLS002153508; CHEMBL28449; SCHEMBL30101819; (2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-N-cyclopropyl-3,4-dihydroxyoxolane-2-carboxamide; HMS2235M15; HMS3372E17; ZINC00057265; 5-(6-aminopurin-9-yl)-N-cyclopropyl-3,4-dihydroxyoxolane-2-carboxamide; PD045110; SMR001230840; DB-051862
CAS 50908-62-8; molecular formula C13H16N6O4; molecular weight — g/mol.
5'-(N-Cyclopropyl)carboxamidoadenosine, 5'-(N-CYCLOPROPYL)-CARBOXAMIDOADENOSINE, REGID_for_CID_1761, MLS002153508, CHEMBL28449, SCHEMBL30101819.
Hazard statements reported: H300, H310, H330.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.